Rybrevant faspro 2,400 MG vial 15ML
Ended Awarded Last action
- Contract number
- SPE2DR26FXS7Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,852
Award facts
- Contract value 100% obligated
- $24,851.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $24,851.64 delivery order to Amerisourcebergen Drug Corp on March 17, 2026, for Rybrevant (selpercatinib) 2,400 mg vials, 15 mL.
The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 through December 2026. Place of performance is Conshohocken, PA. Ultimate completion date is April 7, 2026. Pricing is firm fixed price. No set-aside was used.
Quick answers
Who was awarded contract SPE2DR26FXS7Q?
SPE2DR26FXS7Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on March 17, 2026.
How much is contract SPE2DR26FXS7Q worth?
The government has obligated $24,852 on SPE2DR26FXS7Q.
Is contract SPE2DR26FXS7Q an order under another contract?
Yes. SPE2DR26FXS7Q is a delivery order under SPE2DR25D6029, an indefinite delivery contract.
Was contract SPE2DR26FXS7Q competed?
The extent of competition for SPE2DR26FXS7Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award